Insmed Incorporated

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Insmed Incorporated 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About INSM

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. 

CEO
William H. Lewis
CEOWilliam H. Lewis
Employees
1,664
Employees1,664
Headquarters
Bridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded
1988
Founded1988
Employees
1,664
Employees1,664

INSM Key Statistics

Market cap
21.53B
Market cap21.53B
Price-Earnings ratio
-17.24
Price-Earnings ratio-17.24
Dividend yield
Dividend yield
Average volume
2.87M
Average volume2.87M
High today
$101.50
High today$101.50
Low today
$98.54
Low today$98.54
Open price
$99.16
Open price$99.16
Volume
4.90M
Volume4.90M
52 Week high
$212.75
52 Week high$212.75
52 Week low
$90.39
52 Week low$90.39

Stock Snapshot

Insmed Incorporated(INSM) stock is priced at $101.50, giving the company a market capitalization of 21.53B. It carries a P/E multiple of -17.24.

As of 2026-08-06, Insmed Incorporated(INSM) stock has fluctuated between $98.54 and $101.50. The current price stands at $101.50, placing the stock +3.0% above today's low and 0.0% off the high.

Insmed Incorporated(INSM) shares are trading with a volume of 4.9M, against a daily average of 2.87M.

In the last year, Insmed Incorporated(INSM) shares hit a 52-week high of $212.75 and a 52-week low of $90.39.

In the last year, Insmed Incorporated(INSM) shares hit a 52-week high of $212.75 and a 52-week low of $90.39.

INSM News

Investing.com 17h
InvestingPro’s fair value predicted Insmed’s 45% decline 8 months early By Investing.com - Investing.com

...

InvestingPro’s fair value predicted Insmed’s 45% decline 8 months early By Investing.com - Investing.com
Simply Wall St 6d
Insmed Stock And 2 Healthcare Names To Watch As DOJ Uncertainty Builds

Regulatory headlines around the Department of Justice and corporate taxation can quickly shift how investors view risk, especially for financials and healthcare...

Insmed Stock And 2 Healthcare Names To Watch As DOJ Uncertainty Builds

Analyst ratings

100%

of 25 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own INSM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.